13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001802630
申报总市值
US$29.0亿
US$29.0亿
87 檔
11.1%
在 Q3 2024 申报期间，Soleus Capital Management, L.P.（CIK: 0001802630）向美国 SEC 提交的 Form 13F 报告显示，其追踪之股票投资组合总市值达 US$29.0亿，共持有 87 个公开申报仓位。
Soleus Capital Management, L.P. 在 Q3 2024 进行了结构性的板块轮动与仓位换股。在开立 13 个全新仓位及加仓 10 档持股的同时，亦同步清仓 9 档并减仓 18 档标的。
在资产配置集中度方面，Soleus Capital Management, L.P. 的前 5 大核心持股（包含 XBI, IOVA, TGTX 等）合计占整体申报市值的 11.1%，反映机构在主要关键仓位上的权重分布。
本季最大新建仓标的
XBI
市值: US$8892.0万
本季最大获利了结 / 清仓标的
PEN
前期市值: US$2221.7万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 6.89% | — | — | |
| 2 | IOVA | Iovance Biotherapeutics Inc | 股票-其他 | 6.20% | -0.12% | +12.99% | |
| 3 | TGTX | Tg Therapeutics Inc | 股票-医疗保健 | 4.59% | +0.12% | -30.48% | |
| 4 | 430 | Terns Pharmaceuticals Inc | 股票-其他 | 4.02% | — | +25.79% | |
| 5 | AXGN | Axogen Inc | 股票-其他 | 3.26% | -0.82% | -9.07% | |
| 6 | GRFS | Grifols Sa-adr | 股票-其他 | 3.11% | — | — | |
| 7 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 3.06% | -0.03% | +72.21% | |
| 8 | CCCC | C4 Therapeutics Inc | 股票-其他 | 2.91% | +0.13% | +62.98% | |
| 9 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 2.83% | -0.29% | -27.99% | |
| 10 | SNY | Sanofi-adr | 股票-医疗保健 | 2.73% | — | +879.20% | |
| 11 | ORGO | Organogenesis Holdings Inc | 股票-其他 | 2.62% | -0.12% | +2.79% | |
| 12 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 2.57% | — | +51.18% | |
| 13 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 2.47% | — | -17.71% | |
| 14 | QDEL | Quidelortho CORP | 股票-其他 | 2.42% | — | — | |
| 15 | EPIEUR | Essa Pharma Inc | 股票-其他 | 2.01% | — | +1.84% | |
| 16 | JSPR | Jasper Therapeutics Inc | 股票-其他 | 1.96% | -0.01% | EXIT | |
| 17 | SU6 | Surmodics Inc | 股票-其他 | 1.91% | — | -18.43% | |
| 18 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 1.85% | +0.63% | -48.16% | |
| 19 | TXG | 10x Genomics Inc-class A | 股票-其他 | 1.66% | — | +32.27% | |
| 20 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 1.63% | -0.40% | +32.00% | |
| 21 | ✓ | Merus N V | 股票-其他 | 1.54% | — | +5.85% | |
| 22 | CSTL | Castle Biosciences Inc | 股票-其他 | 1.46% | — | -22.41% | |
| 23 | FOCL | Edap Tms SA -adr | 股票-其他 | 1.44% | +0.20% | +0.21% | |
| 24 | ONC | Beone Medicines Ltd-adr | 股票-其他 | 1.44% | — | -39.91% | |
| 25 | CELC | Celcuity Inc | 股票-其他 | 1.44% | +0.20% | +2.82% | |
| 26 | LLY | Eli Lilly & Co | 股票-医疗保健 | 1.32% | — | — | |
| 27 | NPCE | Neuropace Inc | 股票-其他 | 1.31% | +0.03% | — | |
| 28 | EOLS | Evolus Inc | 股票-其他 | 1.30% | -0.17% | -9.92% | |
| 29 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 1.26% | -1.42% | -17.15% | |
| 30 | ANIP | Ani Pharmaceuticals Inc | 股票-其他 | 1.24% | -0.07% | — | |
| 31 | ELV | Elevance Health Inc | 股票-医疗保健 | 1.19% | — | — | |
| 32 | RIGL | Rigel Pharmaceuticals Inc | 股票-其他 | 1.17% | +2.48% | -10.43% | |
| 33 | PRAX | Praxis Precision Medicines I | 股票-其他 | 1.16% | -2.26% | -51.33% | |
| 34 | KROS | Keros Therapeutics Inc | 股票-其他 | 1.01% | — | +1.35% | |
| 35 | CGON | Cg Oncology Inc | 股票-其他 | 1.00% | -0.04% | -19.78% | |
| 36 | VTLUSD | Immunic Inc | 股票-其他 | 0.93% | -0.20% | EXIT | |
| 37 | BHC | Bausch Health Cos Inc | 股票-医疗保健 | 0.90% | — | +18.08% | |
| 38 | PHVS | Pharvaris N.V. | 股票-其他 | 0.86% | +0.07% | +49.76% | |
| 39 | ✓ | Longboard Pharmaceuticals In | 股票-其他 | 0.82% | — | — | |
| 40 | OFIX | Orthofix Medical Inc | 股票-其他 | 0.73% | — | +1090.06% | |
| 41 | VSTM | Verastem Inc | 股票-其他 | 0.65% | — | +70.23% | |
| 42 | ENTA | Enanta Pharmaceuticals Inc | 股票-其他 | 0.63% | — | -1.75% | |
| 43 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.61% | +0.08% | -6.64% | |
| 44 | ACLXGBX | Arcellx Inc | 股票-其他 | 0.60% | — | -45.51% | |
| 45 | NUVL | Nuvalent Inc-a | 股票-其他 | 0.59% | — | -56.72% | |
| 46 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 0.59% | -0.48% | +51.25% | |
| 47 | ✓ | Biodesix Inc | 股票-其他 | 0.56% | — | -33.93% | |
| 48 | TAK | Takeda Pharmaceutic-sp Adr | 股票-医疗保健 | 0.55% | — | — | |
| 49 | RLAY | Relay Therapeutics Inc | 股票-其他 | 0.50% | — | — | |
| 50 | SMMT | Summit Therapeutics Inc | 股票-其他 | 0.48% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | +6.9% | NEW | 新建仓 |
| 2 | GRFS | Grifols Sa-adr | +3.1% | NEW | 新建仓 |
| 3 | SNY | Sanofi-adr | +2.5% | +879.20% | 加仓 |
| 4 | QDEL | Quidelortho CORP | +2.4% | NEW | 新建仓 |
| 5 | LLY | Eli Lilly & Co | +1.3% | NEW | 新建仓 |
| 6 | CCCC | C4 Therapeutics Inc | +1.3% | +62.98% | 加仓 |
| 7 | ANIP | Ani Pharmaceuticals Inc | +1.2% | NEW | 新建仓 |
| 8 | ELV | Elevance Health Inc | +1.2% | NEW | 新建仓 |
| 9 | AXGN | Axogen Inc | +1.2% | -9.07% | 减仓 |
| 10 | 430 | Terns Pharmaceuticals Inc | +1.1% | +25.79% | 加仓 |
| 11 | KRYS | Krystal Biotech Inc | +1% | +72.21% | 加仓 |
| 12 | IOVA | Iovance Biotherapeutics Inc | +0.9% | +12.99% | 加仓 |
| 13 | ✓ | Longboard Pharmaceuticals In | +0.8% | NEW | 新建仓 |
| 14 | OFIX | Orthofix Medical Inc | +0.7% | +1090.06% | 加仓 |
| 15 | TAK | Takeda Pharmaceutic-sp Adr | +0.6% | NEW | 新建仓 |
| 16 | RLAY | Relay Therapeutics Inc | +0.5% | NEW | 新建仓 |
| 17 | SMMT | Summit Therapeutics Inc | +0.5% | NEW | 新建仓 |
| 18 | BLCO | Bausch + Lomb CORP | +0.5% | NEW | 新建仓 |
| 19 | ARVN | Arvinas Inc | +0.4% | NEW | 新建仓 |
| 20 | TXG | 10x Genomics Inc-class A | +0.4% | +32.27% | 加仓 |
| 21 | IDYA | Ideaya Biosciences Inc | +0.4% | +51.18% | 加仓 |
| 22 | RIGL | Rigel Pharmaceuticals Inc | +0.4% | -10.43% | 减仓 |
| 23 | SLN | Silence Therapeutics Plc-adr | +0.4% | NEW | 新建仓 |
| 24 | EOLS | Evolus Inc | +0.2% | -9.92% | 减仓 |
| 25 | SNDX | Syndax Pharmaceuticals Inc | +0.1% | +32.00% | 加仓 |
| 26 | IRMD | Iradimed CORP | -0.4% | EXIT | 清仓 |
| 27 | INSM | Insmed Inc | -0.4% | -70.46% | 减仓 |
| 28 | ALEC | Alector Inc | -0.5% | -46.08% | 减仓 |
| 29 | JAZZ | Jazz Pharmaceuticals plc | -0.5% | EXIT | 清仓 |
| 30 | GMED | Globus Medical Inc - A | -0.5% | EXIT | 清仓 |
| 31 | NUVL | Nuvalent Inc-a | -0.6% | -56.72% | 减仓 |
| 32 | IMVT | Immunovant Inc | -0.6% | -96.16% | 减仓 |
| 33 | HIMS | Hims & Hers Health Inc | -0.6% | EXIT | 清仓 |
| 34 | TNGX | Tango Therapeutics Inc | -0.6% | -67.32% | 减仓 |
| 35 | CVRX | Cvrx Inc | -0.6% | EXIT | 清仓 |
| 36 | ✓ | Avadel Pharmaceuticals PLC ADR | -0.6% | EXIT | 清仓 |
| 37 | PRAX | Praxis Precision Medicines I | -0.8% | -51.33% | 减仓 |
| 38 | TEVA | Teva Pharmaceutical-sp Adr | -0.8% | EXIT | 清仓 |
| 39 | PCVX | Vaxcyte Inc | -1% | -85.40% | 减仓 |
| 40 | TMCI | Treace Medical Concepts Inc | -1% | -62.47% | 减仓 |
| 41 | SU6 | Surmodics Inc | -1% | -18.43% | 减仓 |
| 42 | ELVN | Enliven Therapeutics Inc | -1.1% | -68.84% | 减仓 |
| 43 | TGTX | Tg Therapeutics Inc | -1.1% | -30.48% | 减仓 |
| 44 | UTHR | United Therapeutics CORP | -1.2% | -27.99% | 减仓 |
| 45 | GSK | Gsk Plc-spon Adr | -1.3% | -90.96% | 减仓 |
| 46 | NARIUSD | Inari Medical Inc | -1.4% | -77.01% | 减仓 |
| 47 | HUM | Humana Inc | -1.5% | EXIT | 清仓 |
| 48 | NRIX | Nurix Therapeutics Inc | -1.9% | -48.16% | 减仓 |
| 49 | PEN | Penumbra Inc | -2% | EXIT | 清仓 |
| 50 | FOCL | Edap Tms SA -adr | -2.1% | +0.21% | 加仓 |
根据 SEC 官方 Form 13F 申报备案，Soleus Capital Management, L.P. 在 Q3 2024 季度的美股持仓总市值约为 US$29.0亿，共申报了 87 个公开持股仓位。
在 Q3 2024 季度，Soleus Capital Management, L.P. 按市值排列的前三大核心持股分别为：XBI (6.9%)、IOVA (6.2%)、TGTX (4.6%)。其中最大持股仓位 XBI 占据整体投资组合约 6.9% 的权重。
在 Q3 2024 季度中，Soleus Capital Management, L.P. 共进行了 50 项持仓异动，包含新建仓 13 个仓位、加仓 10 个仓位、减仓 18 个仓位以及清仓 9 个仓位。 其中最大新建仓标的为 XBI。 本季清仓仓位包含 PEN。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。